AusperBio Secures $37 Million in Series A Financing to Advance AHB-137 Clinical Development for HBV Cure ...Middle East

SAN FRANCISCO, July 14, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure...

Hence then, the article about ausperbio secures 37 million in series a financing to advance ahb 137 clinical development for hbv cure was published today ( Monday 15/07/2024 - 04:34 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Secures $37 Million in Series A Financing to Advance AHB-137 Clinical Development for HBV Cure )

Also on site :

• Country Star Makes Billboard Chart History With No. 1 Hit Song Lasting 28 Weeks
• Innoscience Secures Final Victory in Patent Lawsuit as China's Supreme Court Upholds Injunction Against Infineon GaN Products
• Older runners defy age in Kenya’s central highlands